0 Comentários
0 Compartilhamentos
105 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de Notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Blogs
-
Marketplace
-
Fóruns
-
Faça Login para curtir, compartilhar e comentar!
-
First-in-Class Oncology Drug Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Key Drivers Impacting Executive Summary First-in-Class Oncology Drug Market Market Size and Share The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by rapid advancements in drug discovery technologies, high unmet...0 Comentários 0 Compartilhamentos 525 Visualizações 0 Anterior
-
mTOR Inhibitor Oncology Drug Market Grows with Breakthroughs in Targeted Cancer Therapy"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Forecast CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period Competitive analysis performed in this mTOR Inhibitor Oncology Drug Market...0 Comentários 0 Compartilhamentos 718 Visualizações 0 Anterior
-
Why the Subcutaneous Oncology Biologic Drug Market Is Transforming Cancer Treatment Delivery"Market Trends Shaping Executive Summary Subcutaneous Oncology Biologic Drug Market Market Size and Share CAGR Value The global Subcutaneous Oncology Biologic Drug market size was valued at USD 15.78 billion in 2025 and is expected to reach USD 34.82 billion by 2033, at a CAGR of 10.40% during the forecast period A comprehensive analysis of the market...0 Comentários 0 Compartilhamentos 541 Visualizações 0 Anterior
-
5-Fluorouracil Market Outlook 2031: Growth Trends, Industry Dynamics, and Strategic OpportunitiesThe global 5-Fluorouracil market is witnessing steady expansion, driven by the increasing prevalence of cancer and the continued reliance on chemotherapy-based treatment protocols. 5-Fluorouracil (5-FU) remains one of the most widely used antimetabolite drugs in oncology, particularly for colorectal, breast, and gastrointestinal cancers. According to The Insight Partners, the market is expected...0 Comentários 0 Compartilhamentos 755 Visualizações 0 Anterior
-
Antibody Drug Conjugates Market Expansion with New Cancer TherapiesNorth America currently holds a significant share in the antibody drug conjugates market due to strong research infrastructure and high healthcare spending. The presence of major pharmaceutical companies also supports regional growth. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comentários 0 Compartilhamentos 91 Visualizações 0 Anterior
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Comentários 0 Compartilhamentos 714 Visualizações 0 Anterior
-
Dendritic Cell Cancer Vaccine Market Opportunities in Precision MedicinePharmaceutical companies are expanding their oncology pipelines to include dendritic cell vaccine therapies. Continuous research is leading to the discovery of new therapeutic targets. These advancements are strengthening the market. The Dendritic Cell Cancer Vaccine Market is gaining significant attention in the global oncology landscape as immunotherapy continues to revolutionize cancer...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Investment Trends in the Anti-cancer Drugs MarketThe increasing focus on biologics and biosimilars is transforming the anti-cancer drugs industry. These advanced therapies offer new treatment options for patients with complex cancers. Their rising adoption is expected to drive long-term market expansion. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and increasing...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Is Synthetic Lethality the Future Breakthrough in Targeted Cancer Therapy?Executive Summary Synthetic Lethality Drug Market Size and Share Analysis Report CAGR Value The global Synthetic Lethality Drug market size was valued at USD 1.93 billion in 2025 and is expected to reach USD 8.07 billion by 2033, at a CAGR of 19.60% during the forecast period This Synthetic Lethality Drug Market research report guides the...0 Comentários 0 Compartilhamentos 177 Visualizações 0 Anterior
-
Is the Global Colorectal Cancer Treatment Market Advancing with Breakthrough Oncology Therapies?Executive Summary Colorectal Cancer Treatment Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Market drivers and market restraints...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Market Drivers and Challenges in the Chemotherapy-Induced Peripheral Neuropathy MarketGovernment initiatives and funding programs for cancer research are further contributing to the growth of the chemotherapy-induced peripheral neuropathy market. Increased financial support encourages the development of innovative therapies and clinical studies. The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is gaining significant attention within the global healthcare...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
Páginas Impulsionadas
Patrocinado
Patrocinado
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek